Metaloproteinasa-9 y depresiónestudio en un modelo animal y en muestras cerebrales humanas post-mortem, y papel en el mecanismo de acción de antidepresivos de acción rápida

  1. Senserrich Guerrero, Júlia
Supervised by:
  1. María Elena Castro Fernández Director
  2. María Fuencisla Pilar Cuéllar Director

Defence university: Universidad de Cantabria

Fecha de defensa: 17 March 2023

Committee:
  1. Luis Felipe Callado Hernando Chair
  2. Mónica Tramullas Fernández Secretary
  3. Rebeca Vidal Casado Committee member

Type: Thesis

Teseo: 796993 DIALNET lock_openUCrea editor

Abstract

Major depression is a common mental illness, especially in women. Cannabidiol, the main non-psychomimetic component of Cannabis sativa, presents a potential antidepressant effect. On the other hand, high levels of metalloproteinase 9 (MMP-9) have been observed in models of chronic stress and depressed patients. In this Doctoral Thesis, we delve into the involvement of MMP-9 in depression. We observed an antidepressant-like effect of subchronic cannabidiol administration and the normalization of elevated MMP-9 activity in the corticosterone-induced model of depression. The characterisation of MMP-9 transgenic mice showed that alterations in MMP-9 have a sex-dependent impact at the behavioural, molecular, and neurochemical levels. Finally, we detected elevated MMP-9 activity in post-mortem brain samples from depressed women who committed suicide, but not in men. These findings reinforce the sex-dependent implication of MMP-9 in the etiopathology of depression.